BIGTheme.net • Free Website Templates - Downlaod Full Themes
Super User

Super User

Saturday, 19 April 2014 05:54

Scientific Activities

A- International courses / conferences

2013:

  • 29th Annual meeting of ESHRE, London, United kingdom, 3 to 6 July 2013.

2012:

  • 1st Annual World congress of ICGO, Guangzhou, China, 2 to 4 December 2012
  • 68th Annual meeting of ASRM, San Diego, USA, 22 to 24 October 2012.
  • 28th Annual meeting of ESHRE, Istanbul, Turkey,1 to 5 July 2012.

2011:

  • 27th Annual meeting of ESHRE, Stockhol, Sweden, 3 to 6 July 2011.

2010:

  • Fertility Forum - SHAPE in clinic meeting, Ankara, Turkey, 2 to 3 December 2010.
  • 26th Annual meeting of ESHRE, Rome, Italy, 27 to 30 June 2010.
  • The subfertility and Reproductive Endocrinology course & The Assissted Conception Theoritical course. A collaborative course between the Royal Colleage of Obstetricians and Gynecologists and SMC. Alexandria, 26-30 April 2010.

2009:

  • Intra-cytoplasmic morphologically selected sperm injection (IMSI) workshop held during the 16th annual  meeting of MEFS. Cairo, Egypt, 6 of November 2009.
  • 16th annual meeting of MEFS. Cairo, Egypt, 4 to 7 November 2009.

2005:

  • 12th annual meeting of MEFS, Luxor, Egypt, 23 to 26 November 2005.
  • Workshop on Reproductive Endocrinology and Molecular Biologyheld during the 12th annual meeting of MEFS, Luxor, Egypt, 23 November 2005.
  •  21th Annual Meeting of ESHRE, Copenhagen, Denmark, 20 to 22 June 2005.
  • Certificate of accreditation of 11 - 13 +6 weeks Fetal Ultrasound Scanning, Fetal Medicine Foundation (FMF), linkoping University, Sweden, February 2005.
  •  Training program on advanced gynecological cancer surgery, Lund University, Sweden, 10th - 24th January 2005.
  •  Modern Management Training Program (MMTP) in Egypt, Morocco and Jordan on Health Care Quality Management, international workshop, 1st kick of and Steering Committee Meeting, 11-15 November 2004, Vaxjo University, Sweden.

2004:

  •  20th Annual Meeting of ESHRE, Berlin, Germany, 27 to 30 June 2004.

2003:

  • A joint meeting between The Society for the study of patho-physiology of pregnancy organization gestosis (OG), Basel, Switzerland (35th international annual scientific meeting) and The International Fertility & the Egyptian ICSI Centers (8th international annual scientific congress) Alexandria, 9th & 10th of October, 2003.
  • The 2nd Annual Mediterranean Congress for Reproductive Medicine, Alexandria, 28th -30th of May, 2003

2002:

  •  9th annual scientific congress of the Middle East Fertility Society (MEFS), Cairo from 1/11/2002 to 2/11/2002.

B- Local Courses/Conferences

2011:

  •  25th Annual Scientific Conference of the Department of Obstetrics & Gynecology. Alexandria University,4-6 May 2011

2010:

  •  The fourth Alexandria forum for women’s health and development. The Suzanne Mubarak regional center 24-25 March 2010

2008:

  • The 1st International Annual Conference for Gynecological Endoscopy, Alexandria Faculty of Medicine in collaboration with Egyptian Association of Gynecological Laparoscopies (EAGL), January 31th   – February 1st , Convention Center, Alexandria Faculty of Medicine.
  • 29th Annual scientific congress of Alexandria Faculty of Medicine “Future Medicine”14th-16th of May 2008.

2007:

  • 28th Annual scientific congress of Alexandria Faculty of Medicine “Hospital and Healthcare Management”5th-6th of April 2007.
  • Interactive presentation in medical education workshop, Faculty of Medicine, Alexandria University, 28th-29th March 2007.
  • Alexandria forum for women’s health and development, Suzan Mubarak center, 21st -23rd March 2007.
  • 3rd annual scientific meeting “Updates in woman health”, Egyptian Post Fertility Society in collaboration with Arab Group of Menopause, Helnan Palestine Hotel, Alexandria, Egypt. 15- 16 March 2007.

2006:

  •  27th Annual scientific congress of Alexandria Faculty of Medicine “Medical Research” 23th-24th of March 2006.

2003:

  • Course of operative laparoscopy held in the Egyptian Association of Gynecologic Laparoscopists (EAGL) training center 20/9//2003 till 26/9/2003.
  • Operative endoscopy workshop of the 8th Annual Congress of The Egyptian ICSI Centre, 11th- 12th of October 2003.

2002:

  • MEFS Hysteroscopy Workshop, October 29th & 30th, 2002.
  • Alexandria Fertility and Gynecology Forum by the Alexandria Fertility Center. Alexandria, March 7th & 8th, 2002.
  • The First International Congress of Galaa Assissted Reproduction Unit (GARU), held in Cairo, MAY 23rd & 24th, 2002.
  • 7th Annual Congress of the Egyptian ICSI Centre: New Frontiers in Reproductive Health. Alexandria December12th & 13th, 2002.

2001:

  • 6th Annual Congress of the Egyptian ICSI Centre: New Frontiers in Reproductive Health. Alexandria November 1st & 2nd, 2001.
  • Alexandria Fertility and Gynecology Forum by the Alexandria Fertility Center. Alexandria, March 22nd & 23rd, 2001.
  • Training course for preparation of the university staff members by The University of Alexandria, October, 2001.

2000:

  • 5th Annual Congress of The Egyptian ICSI Centre: Fertility Management: The road to success. Alexandria November 23rd & 24th, 2000.
  • Alexandria Fertility and Gynecology Forum by The Alexandria fertility Center. Alexandria, March 30th & 31st, 2000.
  • Workshop for Training of Trainers (T.O.T) For Obstetrics and Gynecology by The Ministry of health and population and JSI: Healthy Mother and Child Project (in cooperation with USAID). Alexandria, June 2000.
  • The Annual Congress of the Egyptian Fertility and Sterility Society, Cairo, September 19th & 20th, 2000.

1999:

  • Training course for Norplant service provision in family planning by the Regional Center for Training in Family Planning and Reproductive Health. Alexandria February 2nd - March 5th, 1998.
  • 13th Annual Scientific Conference of the Department of Obstetrics & Gynecology. Alexandria, March, 1999.
  •  4th Annual Congress of the Egyptian ICSI Centre: Fertility Management in the 21st Century. Alexandria October 28th & 29th, 1999.

1997:

  •  ECG training course, Alexandria medical syndicate from 15/2/1997 to 15/3/1997.
  • General practitioner training course , Alexandria medical syndicate from 22/3/1997 to 3/4/1997.

C- Local Courses/Conferences Organized

2009:

  • Organizer: Workshop of Menopause: Treasuring the pas – shaping the future. Organized by the Menopause special interest group during the 16th annual meeting of MEFS. Cairo, Egypt, 6 of November 2009.

2003:

  • Organizer: The first annual meeting of the Egyptian Post Menopause Society, Alexandria, 31th July 2003.
  • Organizer: Pre-Congress workshop on Recent Advances in The Management of Polycystic Ovarian Syndrome, for 17h Annual Scientific Conference of The Department of Obstetrics & Gynecology. Alexandria, April 8th & 9th, 2003.
  • Organizer: 17h Annual Scientific Conference of The Department of Obstetrics & Gynecology. Alexandria, April 10th & 11th, 2003.

2002:

  • Organizer: Low Ovarian Response in Infertility. Pre-Congress workshop to The 9th Annual Scientific Congress of The Middle East Fertility Society (MEFS), held by the Reproductive Biology and Molecular Endocrinology Interest Group, Cairo, October 28th, 2002.
  • Organizer: The First Scientific Workshop on Evidence based Medicine: how to apply to Ob-Gyn Practice by The Department of Obstetrics and Gynecology, Alexandria, June 27th, 2002.

2001:

  • Organizer: 16th Annual Scientific Conference of The Department of Obstetrics & Gynecology: New Perspectives in Reproductive Health. Alexandria, May 9th & 10th, 2001.
  • Organizer: Workshop on Infertility, ART, and Applied Molecular Biology, Pre-Congress workshop for 15th Annual Scientific Conference of The Department of Obstetrics & Gynecology. Alexandria, April 17th & 18th, 2001.
  • Organizer: 15th Annual Scientific Conference of The Department of Obstetrics & Gynecology: Reproductive Health in The 21st Century. Alexandria, April 19th & 20th, 2001.

1999:

  • Organizer: 14th international annual scientific congress of the department of obstetrics and gynecology, Alexandria University. 28th - 30th April, 1999.

D. Theses supervised

Thesis

Student

Degree

Year

Comparison between steroid expression in serum and follicular fluid in normogonadotrophic and polycystic ovary patients undergoing assisted reproductive techniques

Dr. Nahla Mahmoud Ahmed

Msc

2009

Comparative evaluation of vascular endothelial growth factor (A) expression in pre ovulatory follicular fluid in normogonadotrophic and endometriotic patients undergoing assisted reproductive techniques

Dr. Nana Mostafa Badr

Msc

2009

Relationship between ultrasound parameters and intracytoplasmic sperm injection outcome in polycystic ovarian syndrome treated by non agonist protocol 

Dr. Sherin Mahmoud Ghazal

Msc

2009

The role of martrix metalloprotinease 2 in the culture media in embryo implantation rate in normogonadotrophic cases undergoing ICSI

Dr. Amr Gamil Koritam

Msc

2010

Effect of folic acid administration on plasma homocystein level in preeclamptic patients

Dr. Seham Atef Morsy

Msc

2010

Comparing the effect of GnRh antagonist versus microdose flare up agonist protocols on ICSI outcome in poor responders

Dr. Ahmed Mohamed Shaban

Msc

2010

Use of herbal medicines and vitamins among pregnant women attending family health centers in Alexandria 

Dr. Mohamed Ibrahim Abd Elaziz

Msc

2010

Prevalence of high risk types hman papilloma virus 16/18 in cytologically abnormal cervical smears in Alexandria, Egypt. A cytological and molecular study.

Dr. Mona Sobhy Alkharashy

Msc

2010

Study of a single neocleotide polymorphism; rs 7903146of  transcription factor 7-like 2 gene with gestational diabetes mellitus in a sample of Egyptian patients

 Dr. Ibrahim Mohamed Foula

 Msc

 2010

 Study of a single nucleotide polymorphism; rs 1788994 of glucokinase gene with gestational diabetes mellitus in a sample of Egyptian patients 

 Dr Nahed Algazar  Msc 2012 

 The role of matrix metalloproteinase-2 in the culture media and embryo implantationrate in normogonadotrophic cases undergoing ICSI 

Dr Amre Koritem   Msc  2012

Gestagen versus oral contraceptive pills to induce withdrawal bleeding before induction of ovulation by clomephine citrate in polycystic ovary syndrome  

 Dr Dina Hassan  Msc 2013 

The effect of immobilization after intrauterine insemination on the improvement of the pregnancy rate  

Dr Noha Salem   Msc  2013

 A comparative study between vaginal contraceptive ring and combined oral contraceptive pills before ICSI cycles 

 Dr Hassan Rizk  Msc  2013

 Fixed gonadotrophin releasing hormone antagonist protocol versus gonadotrophin releasing hormone agonist long protocol in patients with PCO treated for ICSI cycles 

 Dr Doaa Ibrahim  Msc  2013

 Role of Dietary Management of Obesity on Enhancing Pregnancy in Obese Polycystic Ovary Patients Undergoing ICSI 

 Dr Ghadir Samy  PhD  2013

 Endometrial preparation for cryo embryo transfer: effect of GnRha coupled with oestrogen and progesterone on hormonal profile and pregnancy rate 

 Dr hind Abd Allah Aly  Msc  2013

 Comparative study between three methods of stem cell separation from cord blood 

 Dr Mona Alshabasy  PhD  2013

 Day 3 embryo transfer versus day 5 embryo transfer in cases of ICSI  

 Dr Mounira Aly  Msc  2013

 

Friday, 18 April 2014 08:10

Publications & Presentations

  •  Diagnosis of endocervical infection with Chlamydia Trachomatis using the polymerase chain reaction: comparison with chlamydial antigen detection methods.Saleh FM, Rizk AM, Ibrahim MI, and Orief YI. The Egyptian Journal of Fertility and Sterility ;2000.
  • Determination of the prevalence of Chlamydia Trachomatis cervical infection in females having tubal factor of infertility. Saleh FM, Rizk AM, Ibrahim MI, and Orief YI. The Egyptian Journal of Fertility and Sterility ;2000.
Oral Presentations
  • Poor ovarian response: Is there an ideal protocol of management? the Egyptian Fertility Society Conference, 2004, Cairo.
  •  Methods and materials used in perineal repair: an evidence based approach.The 17h Annual Scientific Conference of the Department of Obstetrics & Gynecology. Alexandria, April 8th, 9th, 2003.
  • Molecular genetics in low ovarian responders. Low Ovarian Response in Infertility: Pre-Congress workshop to The 9th Annual Scientific Congress of the Middle East Fertility Society (MEFS), held by The Reproductive Biology and Molecular Endocrinology Interest Group, Cairo, October 28th, 2002.
  • Urinary tract infection in pregnancy: an easy way to manage using the Cochrane database.The First Scientific Workshop on Evidence based Medicine: how to apply to Ob/Gyn Practice, by the Department of Obstetrics and Gynecology, Alexandria, June 27th, 2002.
Friday, 18 April 2014 06:16

الأبحاث و المنشورات

إن أبحاثنا و منشوراتنا الطبية في مجال علاج العقم و أطفال الانابيب نُشرت في أهم المجلات الطبية العالمية و أكثرها إنتشاراً، و تتضمن دراسات بالاضافة إلى أبحاث و محاضرات في المؤتمرات العالمية و هي إن دلت على شئ فانها تدل على تميزنا و إلتزامنا بأحدث الطرق العلمية كي نحقق لكم النجاح.

و هنا تجدون قائمة ببعض منشوراتنا و أبحاثنا الطبية.

 

  •  Diagnosis of endocervical infection with Chlamydia Trachomatis using the polymerase chain reaction: comparison with chlamydial antigen detection methods.Saleh FM, Rizk AM, Ibrahim MI, and Orief YI. The Egyptian Journal of Fertility and Sterility ;2000.
  • Determination of the prevalence of Chlamydia Trachomatis cervical infection in females having tubal factor of infertility. Saleh FM, Rizk AM, Ibrahim MI, and Orief YI. The Egyptian Journal of Fertility and Sterility ;2000.

Oral Presentations

    • Poor ovarian response: Is there an ideal protocol of management? the Egyptian Fertility Society Conference, 2004, Cairo.
    • Methods and materials used in perineal repair: an evidence based approach.The 17h Annual Scientific Conference of the Department of Obstetrics & Gynecology. Alexandria, April 8th, 9th, 2003.
    • Molecular genetics in low ovarian responders. Low Ovarian Response in Infertility: Pre-Congress workshop to The 9th Annual Scientific Congress of the Middle East Fertility Society (MEFS), held by The Reproductive Biology and Molecular Endocrinology Interest Group, Cairo, October 28th, 2002.
    • Urinary tract infection in pregnancy: an easy way to manage using the Cochrane database.The First Scientific Workshop on Evidence based Medicine: how to apply to Ob/Gyn Practice, by the Department of Obstetrics and Gynecology, Alexandria, June 27th, 2002.
Sunday, 16 March 2014 22:55

Risks of Infertility Treatment

Your Fertility Specialist will discuss the possible risks as they relate to you and your partner during the Informed Consent Process.

Anyone taking medication for any reason should be aware of the possible side effects and should report adverse effects to those managing their treatment. The medications used for ART are known to create some minor side effects in women, but there is no evidence of increased risk to a baby born as a result of a properly managed treatment. The operations and anaesthetics used in ART carry similar risks as for any gynaecological operation. For gynaecological operations, the usual risks of serious complication or death are approximately 1 in 5,000.

Here is more information on possible risks:

Ovarian Hyper Stimulation Syndrome (OHSS)
Multiple Pregancy
Cancer
Birth Defects

Sunday, 16 March 2014 22:54

Treatment options

Research has shown that many couples are uncertain, even intimidated, about initiating infertility treatment. Fears about treatment are often based on out-dated or erroneous information.

Recent improvements in medication, micro-surgery and advanced fertility treatments have made healthy pregnancy a possibility for the majority of patients who seek expert infertility advice.

Here are some treatment options:

Ovulation Induction (OI)
Intrauterine insemination
Intra-Cytoplasmic Sperm Injection (ICSI)
Assissted Hatching
Blastocyst Transfer
Testicular Biopsy (TESE)
PGS - Preimplantation Genetic Screening
Embryo Cryopreservation
Healthy Body Mind Program
Infertility and Stress
Acupuncture

Sunday, 16 March 2014 22:53

Male Infertility

Causes of male infertility

Male infertility is very common, affecting about one man in twenty. Male factor is present in almost half of all infertile couples and about one third of all IVF procedures are performed for male factor infertility. For most men the discovery that they are infertile comes as a total surprise.

It must be remembered that the testis have two distinct roles.

The first is to produce the male sex hormone, testosterone, which is important for providing sex drive, erections, strong muscles and basically giving a man a general feeling of well being. All these things can be described as virility.

The second function of the testis is to produce millions of sperm everyday, a process that occurs inside each testis. For most infertile men it is only this process that is at fault and a reduced number or poor quality of sperm are produced.

Most infertile men produce low numbers of sperm, which may also show both poor swimming ability (called motility) and be abnormally shaped (morphology). In such men, only a small number of normally shaped motile sperm are likely to swim up the woman's fallopian tube into the vicinity of the egg and even then may be unable to fertilise the egg.

Why does this problem develop? We now believe that most cases are genetic. In other words, these men are born without the genetic information that would allow sperm production to occur normally. No treatment for men to improve sperm counts is likely to become available. IVF techniques offer hope though, as they require very much fewer normal sperm than does Nature.

In the remaining one third of infertile men, we can find a likely cause for their infertility including:

1. Obstruction to the passage of sperm from the back of the testis to the outside can result from blockage or absence of the vas deferens. Common causes include, obviously, vasectomy, but any history of injury, and other surgery or sexually transmitted disease may be important.

2. Men can make antibodies to their sperm following vasectomy or other trauma or infection. These antibodies are a common cause of infertility and prevent sperm swimming or sticking to the egg. Such antibodies can only be found using a special test on fresh sperm and is available Barbados Fertility Centre.

3. The testis can be damaged by a wide number of treatments including chemotherapy or repeated X-Ray therapy.

4. Some men have difficulties obtaining an erection, or in ejaculating due to a wide range of problems such as diabetes, MS, or previous prostate surgery. In these cases sperm can be found and used for IVF.

5. Rarely, a deficiency in the brain pituitary hormones may result in low sperm counts. Its detection is important as it is readily treated with hormone injections.

Finally studies have shown that sperm counts have declined worldwide. The alleged change is quite small (about 15%) and no cause has been confidently identified, however it is believed to be an environmental factor.

In conclusion while the causes of infertility are uncertain in many men, certain conditions can be identified and treated. These facts make it essential that all infertile men have their situation thoroughly investigated.

Investigations of male infertility

Often the infertile man is entirely healthy but for some reason produces poor quality sperm. However some men have serious medical problems such as a low male sex hormone level - testosterone. It is therefore very important that men in infertile relationships see a doctor trained in reproductive medicine. Previous fertility, genital surgery or infections, undescended testes and certain systemic diseases are of importance.
The most important test is the semen analysis, which requires a great deal of expertise to comply with the high standards prescribed by the World Health Organisation.

Semen quality varies widely between men. Even for a particular man a minimum of two sperm counts at least three weeks apart need to be taken to give a true indication of his sperm quality. The test is performed after two to four days of sexual abstinence.

A sperm count greater than 20 million/ml is considered normal, however the average for the population is about 60 million and some men have a sperm count of above 200 million/ml. Sperm counts between five and 20 million do not necessarily indicate a severe infertility problem. The ability of sperm to swim is termed motility. Normally greater than 40% of sperm show some motility. Markedly reduced motility problems can greatly reduce fertility. The sperm shape, termed morphology, is an important predictor of fertility and the accurate assessment of this feature requires great skill.

Sperm antibodies are an important cause of infertility as they reduce the sperm's motility and ability to stick to the egg. They can be readily detected on fresh sperm at the time of semen analysis and are an essential initial test performed in our laboratory. Another indicating test is the sperm mucus interaction test, which examines the ability of sperm to swim through mucus.

Blood hormone tests are also performed. Poor testicular function can reduce testosterone levels, which in turn impairs sex drive and energy levels. The FSH (Follicle Stimulating Hormone) test gives an indication of the amount of sperm being produced. In normal men or those with a blockage of sperm outflow, FSH levels are normal. However when the testicle is severely damaged, and few or any sperm are being produced, FSH level rises progressively. This is a standard blood test that should be performed routinely if a severe male factor is diagnosed.

A zero sperm count may be due to either blockage in the tubes or to the failure of sperm production. A testicular biopsy, often using a fine needle under local anaesthesia, with microscopic examination by our embryologist, readily clarifies whether sperm are present in the testis. In some cases of blockage, further tests such as ultrasound of the prostate and bladder region can be performed by a Urologist.

In conclusion, thorough clinical assessment of the man and the performance of a range of specialized hormone and sperm tests are needed to for full evaluation.

Sunday, 16 March 2014 22:52

Female Infertility

There are a number of possible causes of female infertility, such as:

Polycystic Ovarian Syndrome (PCOS)
Endometriosis
Fibroids
Age

Sunday, 16 March 2014 22:46

Pre Cycle Testing

Individualised Care: 

An initial assessment of your general health will be performed and previous history will be taken before advising you which tests/investigations you need. The tests may include some or all of the following depending on what you need (a complete list will be given to you once you are a registered patient):

Blood tests (Men and Women)

1. Rubella (German Measles)
All female patients are tested for Rubella immunity. If there is no natural immunity to Rubella, then vaccination must be undertaken before commencing treatment. This eliminates the potential danger of the effects of Rubella with early pregnancy.

2. Hormone levels
Oestrogen, Luteinising Hormone, Thyroid Stimulating Hormone, Prolactin and Follicle Stimulating Hormone levels are generally tested on day 2 or 3 of your cycle prior to treatment to ensure that these are normal.

3. HIV
There are four reasons for performing this test

1) the risk of a pregnancy to a female who is infected with the virus. Pregnancy may have a negative impact on the health of an HIV positive woman.

2) the risk of transmitting the HIV virus to a child during childbirth.

3) the theoretical risk of frozen embryos / gamates transmitting the virus to other patient`s embryos / gametes

4) the risk to fertility centre staff that are handling body fluids from a large population on a daily basis. We would be required to take special precautions with samples from HIV positive patients.

4. Hepatitis B and C
Hepatitis has similar risks to HIV. Hepatitis is more infectious than HIV, although the death rate is much lower. Both partners should be tested. These tests are also of vital importance for the freezing of couples gametes and embryos.

Baseline Ultrasound Scans (Women)

A vaginal ultrasound is required. The reasons for the ultrasound are to:

1. Determine if there are any physical changes, such as fibroids or polyps, that may effect your cycle, and also check for the presence of ovarian cysts;

2. Assess the ease of 'access' to your ovaries, as your eggs will be collected using an ultrasound-guided method;

3. Provide a 'baseline' report that can be used as a reference during your treatment cycle;

4. Measure the size of your ovaries and count the number of small follicles present in your ovaries.

Occasionally you may need other baseline scans done prior to treatment cycles. Most women find a vaginal ultrasound to be a relatively painless and simple procedure. The woman's partner or a support person can be present during the procedure if she wishes. An empty bladder is required for this procedure.

Semen analysis (Men)

Two semen analyses are required. At least one semen analysis should be performed at the our laboratory prior to egg retrievalas test results can vary between laboratories and also over time. These analyses may include tests for sperm antibodies in the semen and checks for possible infection that may affect fertilisation. Details on collection of the sample will be given to you when you make your appointment. Our laboratory also does a detailed preparation to determine what the best technique for preparing your sample is.

Semen production

For some men, providing a semen sample on the day of egg collection can be quite embarrassing and stressful. We endeavour to make this event as easy as possible for you:

  • it is important to remember that the personnel who will be dealing with you and your sample are doing their normal day's work and, although it may not seem so to you, find it quite commonplace.
  • there are alternatives to producing your sample at the Clinic. The sample may be produced off the premises and brought to the Clinic in the appropriate sterile container (as long as the time to travel is within one hour).
  • The sample does not need to be produced by masturbation. Your partner may accompany you .
  • WE also has the ability to freeze your sperm. It could be used as a back-up to prevent any problems occurring on the day of your partner's egg collection. It should be noted that sperm freezing may reduce the motility of your sperm and ICSI may then be required.
Page 3 of 3